NIFFENEGGER KATHI 4
4 · Edesa Biotech, Inc. · Filed Nov 9, 2020
Insider Transaction Report
Form 4
NIFFENEGGER KATHI
Chief Financial Officer
Transactions
- Exercise of In-Money
Common Shares
2020-11-06$4.00/sh+609$2,436→ 1,827 total(indirect: By Trust) - Exercise of In-Money
Common Share Warrants (Right to Buy)
2020-11-06−609→ 0 total(indirect: By Trust)Exercise: $4.00From: 2020-07-08Exp: 2020-11-08→ Common Shares (609 underlying)